Use of Anti-CD26 Antibody Levels as Autoimmune and/or Infl ammatory Disease Biomarkers
Developed by: Instituto de Investigación Sanitaria Galicia Sur
Rheumatoid arthritis (RA) is considered an autoimmune and inflammatory disease. It is the most common form of chronic inflammatory joint disease, and affects 1-2% of the general population. The diagnosis of RA is based on specific parameters such as the number of joints affected or the duration of symptoms. However, the early clinical presentation of RA is indistinguishable from others forms of arthritis.
While there has been progress in the discovery of molecular and serological markers related to RA in recent years, there is still an on-going need for improved methods in early detection, accurate diagnosis, classification, study of the progression and/or prognosis of RA and related autoimmune and inflammatory diseases. For that purpose, an in vitro method to detect a new biomarker for the screening, diagnosis, and/or monitoring of early or very early detection of RA has been created.